Revolutionizing Immunology with Oral Medicines
May 15, 2026
Revolutionizing Immunology with Oral Medicines
American Thoracic Society (ATS) – Respiratory Innovation Summit 2026
Michael Feldman, MD, PhD, Executive Medical Director
Area of Focus
Immunology
Programs
STAT6 (KT-621)
Indications
Atopic Dermatitis (AD)
Asthma
Development Stage
Clinical Data
Share
